Thoracic outlet syndrome is a group of disorders that cause pain in the neck, shoulder, and arms, and numbness and tingling of the fingers.
Global Thoracic Outlet Syndrome (TOC) Treatment Market: Introduction
Thoracic outlet syndrome (TOC) is a group of disorders that cause pain in the neck, shoulder, and arms, and numbness and tingling of the fingers. The thoracic outlet syndrome is caused by the compression of blood vessels and nerves in the space between the collarbone and the first rib known as thoracic outlet.
Read Report Overview - https://www.transparencymarketresearch.com/thoracic-outlet-syndrome-treatment-market.html
The common causes of thoracic outlet syndrome include damage to the shoulder or neck, injuries caused because of sports-related activities, anatomical defects, tumors in chest, and obesity. The three types of thoracic outlet syndromes are neurogenic, vascular, and non-specific. Treatment of thoracic outlet syndrome includes therapeutic drugs such as anti-inflammatory drugs, anti-coagulation drugs, and muscle relaxants. When medicinal therapy does not improve the symptoms of thoracic outlet syndrome, surgical treatments are performed to relive them.
Key Drivers of Global Thoracic Outlet Syndrome (TOC) Treatment Market
Rise in prevalence of Lung Injuries, Lung Tumors, Congestive Heart Failure, and Lymph or Blood Vessels Blockages
According to the Journal of Aerosol Medicine and Pulmonary Drug Delivery, incidence of acute lung injuries is considerably high (200,000 per year in the U.S.), and overall mortality is also high. According to the World Health Organization, lungs are highly vulnerable to infection and injury from the external environment because of constant exposure to particles, chemicals, and infectious organisms in the ambient air.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46455
Globally, at least 2 billion people are exposed to toxic smoke of biomass fuel, typically burned inefficiently in poorly ventilated indoor stoves or fireplaces. Lung cancer is the most common lethal neoplasm in the world, which accounts for 1.6 million deaths each year, and the number is increasing. According to the World Heart Federation, the prevalence of heart failure is rising globally to an estimated number of 26 million, with additional millions of undiagnosed cases.
Rise in Prevalence of Pleural Effusion
According to the Journal of the Nigeria Medical Association, the incidence of pleural effusion in the U.S. is estimated at 1.5 million cases annually. Dyspnea is the most common symptom of pleural effusion. According to Stat Pearls Publishing LLC, pleural effusion is a highly common disease among all pleural diseases and affects 1.5 million people in the U.S. each year.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=46455
North America to Account for Major Share of Global Thoracic Outlet Syndrome (TOC) Treatment Market
North America is projected to account for significant share of the global market owing to easy availability of NSAID drugs, rapidly increasing geriatric population, and well-established health care facilities. Europe is anticipated to constitute major share of the global thoracic outlet syndrome treatment market by 2031. The market in Asia Pacific is expected to expand at a high CAGR during the forecast period owing to increase in number of patients with thoracic outlet syndrome in China, India, and Japan, changing health care infrastructure in the region, and easy availability of therapeutic drugs.
Pre Book Thoracic Outlet Syndrome (TOC) Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=46455<ype=S
Key Players Operating in Global Thoracic Outlet Syndrome (TOC) Treatment Market
The global thoracic outlet syndrome (TOC) treatment market is highly consolidated owing to the presence of small number of key players. Leading players operating in the global thoracic outlet syndrome (TOC) treatment market are:
- Pfizer, Inc.
- Mylan N.V.
- F. Hoffmann-La Roche AG
- Novartis AG
- Allergan plc
- Piramal Critical Care, Inc.
- Apotex, Inc.
- Shire plc
- Validus Pharmaceuticals LLC
Browse More Reports by Transparency Market Research:
Prepacked Chromatography Columns Market: The global prepacked chromatography columns market was valued at US$1.3bn in 2015, and analysts predict that it will attain a total value of US$3.3bn by the end of 2024. Given these figures, the prepacked chromatography columns market is expected to grow at a substantial CAGR of 8.4% during the forecast period.
Biologics Market: The biologics market is expected to grow at an impressive pace during the forecast period. The gains will be driven by substantial investments in research and developmental activities in the biotechnology and pharmaceutical sector and the soaring demand for novel therapies for various rare diseases.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453